Project Grant R01NS144063
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Missouri System a $622,881 Project Grant on August 5, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support research on novel mechanisms of metabolic reprogramming of reactive astrocytes and brain repair after focal cerebral ischemia (FCI). The five-year award extends through July 31, 2030, and is being...
- Federal Project Grant Award Summary Colorado State University received a $496,279 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective March 1, 2026, through November 30, 2030. The award funds fundamental neuroscience research investigating cholinergic synaptic homeostasis (HSP)—the compensatory mechanisms neurons employ to maintain...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $137,687 to the University of Missouri at Kansas City on March 9, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support a two-year research project concluding February 28, 2028. This Project Grant funds basic neuroscience research investigating gene-regulatory mechanisms that govern neuronal circuit formation using...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University $488,232 under its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2030. This Project Grant funds research exploring activity-dependent regulation of intracellular and intercellular mitochondrial transport in astrocytes—specialized brain support cells that facilitate...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Washington University a Project Grant totaling $231,264 on April 8, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This research project, titled "Transcriptomic Signatures of Ischemic Stroke: Unlocking Human-Specific Targets for Cerebroprotection," will be conducted at the institution's St. Louis,...
- Federal Grant Award Summary The University of Missouri System received a $572,715 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025, through June 30, 2030. The research project investigates spinal dopamine receptor mechanisms regulating the micturition reflex following spinal cord injury (SCI). The project will deliver...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Alabama at Birmingham a Project Grant of $186,250 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) on January 15, 2026, with a completion date of December 31, 2027. This research project investigates the role of presynaptic mechanisms in modulating AMPA receptor (AMPAR) biophysical properties at mossy...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Columbia University's Health Sciences Division a Project Grant of $126,900 effective May 1, 2026, through April 30, 2028, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This research initiative, titled "Dissecting the Synaptic and Molecular Mechanisms of Cell-Type-Specific Memory Computation in Hippocampal CA3,"...
- Federal Grant Award Summary This $585,999 Project Grant, awarded June 1, 2026, by the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), supports fundamental neuroscience research conducted at Pennsylvania State University's Milton S. Hershey Medical Center in Hershey, Pennsylvania. The research deliverables focus on elucidating the principles underlying cerebellothalamocortical...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a Project Grant totaling $388,646 (awarded June 16, 2026; completion date May 31, 2031) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research project investigates the molecular mechanisms of delta-2 receptor (GluD2) dysfunction in neurological diseases, specifically examining how...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Missouri System a Project Grant totaling $329,234 on June 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The research project, titled "Transforming Synapses to Operate During Extreme Metabolic Dysfunction," will be conducted in Columbia, Missouri, and is scheduled for completion by May 31, 2031. This research initiative addresses fundamental neuroscience questions regarding how the brain maintains synaptic function during severe energy deficiency—a condition common to multiple neurological disorders including stroke, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). The primary deliverable is basic research that reverse-engineers synaptic adaptation mechanisms identified in hibernating frog brains, which demonstrate a 30-fold improvement in synaptic survival without oxygen and glucose delivery. The project will employ multiple physiological techniques to investigate three complementary mechanisms: enabling brain glycogen utilization as a primary fuel source, maintaining neural network connectivity through metabolite-mediated synaptic strengthening, and reducing pathological calcium influx to constrain neuronal excitability. Findings from this research are expected to generate foundational knowledge applicable to therapeutic interventions across multiple neurological diseases affected by metabolic dysfunction.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $329.2k | 6/9/26 |